Acknowledgments Under the direction of the authors, medical writing and editorial support, including the literature search, were provided by Graham Allcock of Axis, a division of Spirit Medical Communications Group Limited (funded by Novo Nordisk A/S)
Always listen to your healthcare provider and do what they say
When used as part of CagriSema, the dosing schedule looked like this in trials: Weeks 04: 0.25 mg cagrilintide + 0.25 mg semaglutide Weeks 48: 0.5 mg + 0.5 mg Weeks 812: 1 mg + 1 mg Weeks 1216: 1.7 mg + 1.7 mg Week 16 onward: 2.4 mg + 2.4 mg (full maintenance dose) Until the medication is approved and prescribing information is finalized, any dosing decisions would only happen through participation in a clinical trial or, eventually, under the guidance of a healthcare provider
Massieren Sie sie sanft ein, um die Aufnahme zu frdern
That is the direct answer
Some formulations also come at 2.5mg/mL for patients on starting doses who need more precise low-volume measurements